裸盖菇素对小鼠脑微结构的影响
研究将11至15周龄C57BL/6J雄性小鼠随机分配接受裸盖菇素、6-氟-N,N-二乙基色胺或生理盐水,在治疗后24小时(n=18)和72小时(n=18)进行离体扩散MRI成像,采用单因素方差分析及Bonferroni校正比较感兴趣区的扩散指标差异。结果显示裸盖菇素组在72小时额叶联合皮质平均纤维束长度较生理盐水组增加(P=0.03),24小时初级视觉皮质平均扩散率增加(P=0.02),72小时纹状体平均扩散率增加(P=0.02)且神经突密度指数降低(P=0.02),海马平均扩散率增加(P=0.04)且神经突密度指数降低(P=0.02)。作者认为扩散微结构成像和white matter tractography是检测裸盖菇素治疗相关神经基质和微结构差异的敏感方法。
要点
- 裸盖菇素组72小时额叶联合皮质平均纤维束长度较生理盐水组增加(P=0.03)。
- 裸盖菇素组24小时初级视觉皮质平均扩散率较生理盐水组增加(P=0.02)。
- 裸盖菇素组72小时纹状体和海马平均扩散率增加且神经突密度指数降低(P=0.02至0.04)。
核心结论
- 扩散微结构成像和white matter tractography是检测和表征裸盖菇素治疗伴随的神经基质及微结构差异的敏感方法,提示扩散微结构成像可能用于量化裸盖菇素等致幻剂对大脑的生物效应、监测治疗反应并识别重度抑郁障碍患者新兴治疗方案的 salient clinical end points。
研究设计与样本
- 研究论文;11至15周龄C57BL/6J雄性小鼠随机分配接受裸盖菇素、6-氟-N,N-二乙基色胺或生理盐水,治疗后24小时(n=18)和72小时(n=18)进行离体扩散MRI成像;采用单因素方差分析及Bonferroni校正多重比较,评估感兴趣区(杏仁核、纹状体、海马、丘脑、初级视觉皮质区、额叶联合皮质、内侧前额叶皮质)的扩散指标(纤维束成像、DTI、神经突方向离散度和密度成像)差异。
诊断标准与关键数值
- 裸盖菇素组与生理盐水组比较:72小时额叶联合皮质平均纤维束长度增加,P=0.03。
- 裸盖菇素组与生理盐水组比较:24小时初级视觉皮质平均扩散率增加,P=0.02。
- 裸盖菇素组与生理盐水组比较:72小时纹状体平均扩散率增加(P=0.02)且神经突密度指数降低(P=0.02)。
- 裸盖菇素组与生理盐水组比较:72小时海马平均扩散率增加(P=0.04)且神经突密度指数降低(P=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: There is surging interest in the therapeutic potential of psychedelic compounds like psilocybin in the treatment of psychiatric illnesses like major depressive disorder (MDD). Recent studies point to the rapid antidepressant effect of psilocybin; however, the biologic mechanisms underlying these differences remain unknown. This study determines the feasibility of using diffusion MRI to characterize and define the potential spatiotemporal microstructural differences in the brain following psilocybin treatment in C57BL/6J male mice.
MATERIALS AND METHODS: Eleven- to 15-week-old C57BL/6J male mice were randomly assigned to receive psilocybin, 6-fluoro-N, N-diethyltryptamine, or saline and ex vivo imaged 24 hours (n=18) and 72 hours (n=18) posttreatment. A 1-way ANOVA with multiple comparison testing (Bonferroni correction) assessed diffusion metric differences (tractography, DTI, neurite orientation dispersion and density imaging) between the 3 groups and was performed in the following regions of interest: amygdala, striatum, hippocampus, thalamus, primary visual cortex area, frontal association cortex, and medial prefrontal cortex at 24 hours and 72 hours postdrug administration.
RESULTS: Psilocybin-treated mice demonstrated structural connectivity differences at 72 hours in the frontal association cortex (compared with saline, mean tract length increases, P = .03). Psilocybin also induced microstructural differences at 24 hours postinjection in the primary visual cortex (compared with saline, mean diffusivity [MD] increases, P = .02) and 72 hours postinjection in the striatum (compared with saline; MD increases, P = .02, neurite density index [NDI] decreases, P = .02) and hippocampus (compared with saline; MD increases, P = .04, NDI decreases, P = .02).
CONCLUSIONS: Diffusion microstructure imaging and white matter tractography are sensitive methods to detect and characterize the neural substrates and microstructural differences accompanying psilocybin treatment. These findings suggest the potential role for diffusion microstructure imaging to quantify the bioeffects of psychedelics like psilocybin on the brain, monitor treatment response, and identify salient clinical end points in an emerging therapeutic option for patients with MDD.
引用
- Frautschi PC, Singh AP, Stowe NA, et al. Effects of Psilocybin on Mouse Brain Microstructure. AJNR Am J Neuroradiol. 2025. PMID: 39880687. doi:10.3174/ajnr.A8634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。